Arvee Laboratories (India) standalone net profit rises 6.00% in the June 2021 quarter

Arvee Laboratories (India) standalone net profit declines 31.75% in the March 2021 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Arvee Laboratories provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates

Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd

Scorecard

News & Opinions

Arvee Laboratories (India) standalone net profit rises 6.00% in the June 2021 quarter

Arvee Laboratories (India) standalone net profit declines 31.75% in the March 2021 quarter